NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has exclusively licensed rights to Proteome Sciences’ TMT isobaric mass tag technology, the Cobham, UK-based firm announced yesterday.
 
Proteome Sciences will manufacture the TMT reagents and Thermo Fisher will market and sell them through its Pierce product line. The TMT patents expire in 2021, and Thermo Fisher has the right to provide third-party commercial licenses for use of any type of isobaric tandem mass tags.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.